Skip to content
RDL Network logo
Efficacy of Chemotherapy in <i>BRCA1/2</i> Mutation Carrier Ovarian Cancer in the Setting of PARP Inhibitor Resistance: A Multi-Institutional Study — Joo Ern Ang (2013) | RDL Network